

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | keratinocyte development (GO:0003334) | 6.90164370 |
| 2 | terpenoid biosynthetic process (GO:0016114) | 5.61565075 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.42931465 |
| 4 | nephron tubule formation (GO:0072079) | 5.41031338 |
| 5 | ear development (GO:0043583) | 5.40422793 |
| 6 | glomerular visceral epithelial cell development (GO:0072015) | 5.25218668 |
| 7 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.21261585 |
| 8 | hemidesmosome assembly (GO:0031581) | 5.12136250 |
| 9 | lung lobe morphogenesis (GO:0060463) | 4.98980472 |
| 10 | glomerular epithelial cell development (GO:0072310) | 4.84639343 |
| 11 | regulation of cardioblast differentiation (GO:0051890) | 4.78790032 |
| 12 | cornea development in camera-type eye (GO:0061303) | 4.77707223 |
| 13 | keratinocyte proliferation (GO:0043616) | 4.71708650 |
| 14 | glomerular basement membrane development (GO:0032836) | 4.39564019 |
| 15 | artery smooth muscle contraction (GO:0014824) | 4.36417074 |
| 16 | wound healing, spreading of epidermal cells (GO:0035313) | 4.29820845 |
| 17 | intestinal epithelial cell development (GO:0060576) | 4.28200546 |
| 18 | macrophage chemotaxis (GO:0048246) | 4.24657331 |
| 19 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 4.19203207 |
| 20 | lung vasculature development (GO:0060426) | 4.13432406 |
| 21 | lung-associated mesenchyme development (GO:0060484) | 3.99131144 |
| 22 | negative regulation of kidney development (GO:0090185) | 3.97327543 |
| 23 | primary alcohol catabolic process (GO:0034310) | 3.96689117 |
| 24 | folic acid transport (GO:0015884) | 3.96449635 |
| 25 | tonic smooth muscle contraction (GO:0014820) | 3.93884348 |
| 26 | cysteine metabolic process (GO:0006534) | 3.91683807 |
| 27 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.90694650 |
| 28 | desmosome organization (GO:0002934) | 3.89772915 |
| 29 | skin morphogenesis (GO:0043589) | 3.88542676 |
| 30 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.87701624 |
| 31 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 3.85868040 |
| 32 | transepithelial transport (GO:0070633) | 3.83894835 |
| 33 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.81564545 |
| 34 | regulation of water loss via skin (GO:0033561) | 3.80398210 |
| 35 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.76494502 |
| 36 | transcytosis (GO:0045056) | 3.75964483 |
| 37 | axonemal dynein complex assembly (GO:0070286) | 3.75797286 |
| 38 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.75285103 |
| 39 | negative regulation of metanephros development (GO:0072217) | 3.71494271 |
| 40 | lung epithelium development (GO:0060428) | 3.67768881 |
| 41 | diterpenoid biosynthetic process (GO:0016102) | 3.67142850 |
| 42 | sulfur amino acid catabolic process (GO:0000098) | 3.66142381 |
| 43 | galactose catabolic process (GO:0019388) | 3.66090054 |
| 44 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.61837775 |
| 45 | positive regulation of osteoblast proliferation (GO:0033690) | 3.61815914 |
| 46 | regulation of complement activation (GO:0030449) | 3.59086273 |
| 47 | regulation of protein activation cascade (GO:2000257) | 3.57659093 |
| 48 | inositol phosphate-mediated signaling (GO:0048016) | 3.57594871 |
| 49 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.53189599 |
| 50 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.53189599 |
| 51 | endocrine process (GO:0050886) | 3.53189599 |
| 52 | epithelial cell-cell adhesion (GO:0090136) | 3.51573424 |
| 53 | energy homeostasis (GO:0097009) | 3.49477694 |
| 54 | positive regulation of odontogenesis (GO:0042482) | 3.47212085 |
| 55 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.46831548 |
| 56 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.46432216 |
| 57 | pattern specification involved in kidney development (GO:0061004) | 3.44800903 |
| 58 | galactose metabolic process (GO:0006012) | 3.42989251 |
| 59 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.40815557 |
| 60 | wound healing, spreading of cells (GO:0044319) | 3.40775429 |
| 61 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.39547040 |
| 62 | keratan sulfate catabolic process (GO:0042340) | 3.39002415 |
| 63 | negative regulation of cell fate specification (GO:0009996) | 3.36423404 |
| 64 | regulation of keratinocyte proliferation (GO:0010837) | 3.35814653 |
| 65 | prostanoid biosynthetic process (GO:0046457) | 3.34348890 |
| 66 | prostaglandin biosynthetic process (GO:0001516) | 3.34348890 |
| 67 | gap junction assembly (GO:0016264) | 3.31951689 |
| 68 | complement activation, alternative pathway (GO:0006957) | 3.31818795 |
| 69 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.31540427 |
| 70 | cell adhesion mediated by integrin (GO:0033627) | 3.30753961 |
| 71 | tight junction assembly (GO:0070830) | 3.29193824 |
| 72 | regulation of axon regeneration (GO:0048679) | 3.28771413 |
| 73 | regulation of neuron projection regeneration (GO:0070570) | 3.28771413 |
| 74 | L-ascorbic acid metabolic process (GO:0019852) | 3.27755201 |
| 75 | regulation of transforming growth factor beta1 production (GO:0032908) | 3.27501354 |
| 76 | mesodermal cell differentiation (GO:0048333) | 3.24834747 |
| 77 | positive regulation of pseudopodium assembly (GO:0031274) | 3.24694927 |
| 78 | mesonephros development (GO:0001823) | 3.23726872 |
| 79 | retinoic acid metabolic process (GO:0042573) | 3.22006245 |
| 80 | * interferon-gamma secretion (GO:0072643) | 3.21100900 |
| 81 | lateral sprouting from an epithelium (GO:0060601) | 3.16325963 |
| 82 | citrulline biosynthetic process (GO:0019240) | 3.14176259 |
| 83 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.14001711 |
| 84 | negative regulation of neurological system process (GO:0031645) | 3.13155055 |
| 85 | asymmetric protein localization (GO:0008105) | 3.13017030 |
| 86 | amino-acid betaine metabolic process (GO:0006577) | 3.12956052 |
| 87 | oocyte development (GO:0048599) | 3.12091229 |
| 88 | establishment of planar polarity (GO:0001736) | 3.11818139 |
| 89 | establishment of tissue polarity (GO:0007164) | 3.11818139 |
| 90 | embryonic heart tube development (GO:0035050) | 3.11817336 |
| 91 | ethanol oxidation (GO:0006069) | 3.11149423 |
| 92 | apical protein localization (GO:0045176) | 3.10605379 |
| 93 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.10317240 |
| 94 | 4-hydroxyproline metabolic process (GO:0019471) | 3.07837592 |
| 95 | Golgi transport vesicle coating (GO:0048200) | 3.07230568 |
| 96 | COPI coating of Golgi vesicle (GO:0048205) | 3.07230568 |
| 97 | norepinephrine metabolic process (GO:0042415) | 3.06376671 |
| 98 | cilium movement (GO:0003341) | 3.06255918 |
| 99 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.05798714 |
| 100 | establishment of skin barrier (GO:0061436) | 3.04485186 |
| 101 | glutathione biosynthetic process (GO:0006750) | 3.04292463 |
| 102 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.04193859 |
| 103 | hepatocyte apoptotic process (GO:0097284) | 3.04164863 |
| 104 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.03301059 |
| 105 | cell-cell junction assembly (GO:0007043) | 3.03166940 |
| 106 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.03143355 |
| 107 | ruffle organization (GO:0031529) | 3.02507751 |
| 108 | face development (GO:0060324) | 3.01313190 |
| 109 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.00794843 |
| 110 | L-phenylalanine metabolic process (GO:0006558) | 3.00794843 |
| 111 | folic acid metabolic process (GO:0046655) | 2.99822239 |
| 112 | glutathione derivative biosynthetic process (GO:1901687) | 2.97430342 |
| 113 | glutathione derivative metabolic process (GO:1901685) | 2.97430342 |
| 114 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.96155766 |
| 115 | L-phenylalanine catabolic process (GO:0006559) | 2.94777764 |
| 116 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.94777764 |
| 117 | hepatocyte differentiation (GO:0070365) | 2.94388456 |
| 118 | kynurenine metabolic process (GO:0070189) | 2.93469312 |
| 119 | positive regulation of heart rate (GO:0010460) | 2.92692748 |
| 120 | morphogenesis of embryonic epithelium (GO:0016331) | 2.92404382 |
| 121 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.91916150 |
| 122 | regulation of glomerulus development (GO:0090192) | 2.90529052 |
| 123 | xenobiotic catabolic process (GO:0042178) | 2.89106872 |
| 124 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.88718601 |
| 125 | epithelial cilium movement (GO:0003351) | 2.87725041 |
| 126 | vitamin transmembrane transport (GO:0035461) | 2.87455581 |
| 127 | establishment of apical/basal cell polarity (GO:0035089) | 2.85466626 |
| 128 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.85348705 |
| 129 | vascular smooth muscle contraction (GO:0014829) | 2.85299631 |
| 130 | retinal metabolic process (GO:0042574) | 2.84195241 |
| 131 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.83636416 |
| 132 | hypotonic response (GO:0006971) | 2.82939610 |
| 133 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.82795790 |
| 134 | lens fiber cell development (GO:0070307) | 2.81925410 |
| 135 | ethanol metabolic process (GO:0006067) | 2.81835553 |
| 136 | regulation of glomerular filtration (GO:0003093) | 2.81742470 |
| 137 | positive regulation of actin filament depolymerization (GO:0030836) | 2.80682627 |
| 138 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.80140513 |
| 139 | labyrinthine layer development (GO:0060711) | 2.79738025 |
| 140 | response to interferon-beta (GO:0035456) | 2.79517844 |
| 141 | regulation of pseudopodium assembly (GO:0031272) | 2.79324094 |
| 142 | modified amino acid transport (GO:0072337) | 2.76638504 |
| 143 | multicellular organismal water homeostasis (GO:0050891) | 2.76270562 |
| 144 | aromatic amino acid family catabolic process (GO:0009074) | 2.75912288 |
| 145 | embryonic camera-type eye development (GO:0031076) | 2.75858136 |
| 146 | regulation of cell fate specification (GO:0042659) | 2.75765565 |
| 147 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.75475536 |
| 148 | type B pancreatic cell proliferation (GO:0044342) | 2.74680868 |
| 149 | hormone catabolic process (GO:0042447) | 2.74530148 |
| 150 | apoptotic cell clearance (GO:0043277) | 2.73746070 |
| 151 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.72877539 |
| 152 | positive regulation of glomerulus development (GO:0090193) | 2.72347508 |
| 153 | urea metabolic process (GO:0019627) | 2.72046465 |
| 154 | urea cycle (GO:0000050) | 2.72046465 |
| 155 | water homeostasis (GO:0030104) | 2.71474330 |
| 156 | positive regulation of catenin import into nucleus (GO:0035413) | 2.70916232 |
| 157 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.70484611 |
| 158 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.68773247 |
| 159 | tryptophan catabolic process (GO:0006569) | 2.68453671 |
| 160 | indole-containing compound catabolic process (GO:0042436) | 2.68453671 |
| 161 | indolalkylamine catabolic process (GO:0046218) | 2.68453671 |
| 162 | hippo signaling (GO:0035329) | 2.68352092 |
| 163 | surfactant homeostasis (GO:0043129) | 2.68342162 |
| 164 | negative regulation of protein activation cascade (GO:2000258) | 2.68215963 |
| 165 | positive regulation of p38MAPK cascade (GO:1900745) | 2.67986882 |
| 166 | serine family amino acid catabolic process (GO:0009071) | 2.62641163 |
| 167 | growth hormone receptor signaling pathway (GO:0060396) | 2.62161907 |
| 168 | heme transport (GO:0015886) | 2.62019820 |
| 169 | fibrinolysis (GO:0042730) | 2.60453618 |
| 170 | regulation of cholesterol homeostasis (GO:2000188) | 2.60436084 |
| 171 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.59397241 |
| 172 | protein carboxylation (GO:0018214) | 2.59397241 |
| 173 | regulation of alkaline phosphatase activity (GO:0010692) | 2.59325977 |
| 174 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.57948070 |
| 175 | iron coordination entity transport (GO:1901678) | 2.57453507 |
| 176 | negative regulation of complement activation (GO:0045916) | 2.55973409 |
| 177 | alpha-linolenic acid metabolic process (GO:0036109) | 2.55603903 |
| 178 | atrioventricular valve morphogenesis (GO:0003181) | 2.55228216 |
| 179 | regulation of hippo signaling (GO:0035330) | 2.55210893 |
| 180 | vitamin transport (GO:0051180) | 2.53929950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.56934664 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.54518120 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.74901955 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.94141139 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.78132188 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.60732060 |
| 7 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.42743329 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.31991794 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.25557592 |
| 10 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.19812088 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.13996475 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.10127039 |
| 13 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.06080498 |
| 14 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90806044 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.86704054 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.71031387 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.69895468 |
| 18 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.50114712 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.33546825 |
| 20 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 2.31850180 |
| 21 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.30080356 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.28328927 |
| 23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.27610402 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.23256360 |
| 25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.16195729 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.15673533 |
| 27 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.12944491 |
| 28 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 2.12817015 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.12484744 |
| 30 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.11383613 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.09287247 |
| 32 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.08556626 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.02976023 |
| 34 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 2.00838622 |
| 35 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.95884194 |
| 36 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.91228180 |
| 37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.90170618 |
| 38 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.90133752 |
| 39 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.90133752 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89388764 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.88520797 |
| 42 | * ELF5_23300383_ChIP-Seq_T47D_Human | 1.84448099 |
| 43 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.80822620 |
| 44 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.72516119 |
| 45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.71083263 |
| 46 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68120502 |
| 47 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.67681775 |
| 48 | ATF3_27146783_Chip-Seq_COLON_Human | 1.63082944 |
| 49 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.60744679 |
| 50 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.58961157 |
| 51 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56108826 |
| 52 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.55225334 |
| 53 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.54630445 |
| 54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50470254 |
| 55 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.49606110 |
| 56 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.47158720 |
| 57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.46962342 |
| 58 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.46494842 |
| 59 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.45779475 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.43725803 |
| 61 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.42754060 |
| 62 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.42059487 |
| 63 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.33067478 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32482687 |
| 65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32038032 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30511376 |
| 67 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.27677488 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.26041399 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21141457 |
| 70 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19030517 |
| 71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.16692729 |
| 72 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15442694 |
| 73 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15289424 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13769417 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12776209 |
| 76 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12304450 |
| 77 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10171575 |
| 78 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.09748653 |
| 79 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06623418 |
| 80 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05423876 |
| 81 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.04821692 |
| 82 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.04350163 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01373997 |
| 84 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99965751 |
| 85 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99305955 |
| 86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97523662 |
| 87 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95758133 |
| 88 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95752727 |
| 89 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.95633720 |
| 90 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95619235 |
| 91 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.94638802 |
| 92 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94518793 |
| 93 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.92275450 |
| 94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91770389 |
| 95 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.91635103 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90852666 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89093081 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.88902553 |
| 99 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88800291 |
| 100 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87716094 |
| 101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87582991 |
| 102 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86566451 |
| 103 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84777360 |
| 104 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84340337 |
| 105 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.82813312 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81748615 |
| 107 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81084054 |
| 108 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80610431 |
| 109 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79928943 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.79811297 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79279379 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77019377 |
| 113 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76124466 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75631140 |
| 115 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75631140 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75410119 |
| 117 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.72606743 |
| 118 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.72606743 |
| 119 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.72606743 |
| 120 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.72460459 |
| 121 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.69379291 |
| 122 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.69054799 |
| 123 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.67707403 |
| 124 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.66845284 |
| 125 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.66446406 |
| 126 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.66053252 |
| 127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.65626225 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.65415058 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64818920 |
| 130 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.61462218 |
| 131 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.59029788 |
| 132 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.58795956 |
| 133 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.58618462 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.73233290 |
| 2 | MP0002254_reproductive_system_inflammat | 4.53932517 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.60818857 |
| 4 | MP0010386_abnormal_urinary_bladder | 3.21303883 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.20908359 |
| 6 | MP0003878_abnormal_ear_physiology | 2.81306424 |
| 7 | MP0005377_hearing/vestibular/ear_phenot | 2.81306424 |
| 8 | MP0004264_abnormal_extraembryonic_tissu | 2.72251242 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.63574884 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.44591709 |
| 11 | MP0005365_abnormal_bile_salt | 2.43822166 |
| 12 | MP0004019_abnormal_vitamin_homeostasis | 2.40362972 |
| 13 | MP0010678_abnormal_skin_adnexa | 2.36426373 |
| 14 | MP0000537_abnormal_urethra_morphology | 2.35458040 |
| 15 | MP0003566_abnormal_cell_adhesion | 2.34008857 |
| 16 | MP0004272_abnormal_basement_membrane | 2.25083139 |
| 17 | MP0009840_abnormal_foam_cell | 2.20308977 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.16303704 |
| 19 | MP0001881_abnormal_mammary_gland | 2.14501132 |
| 20 | MP0003183_abnormal_peptide_metabolism | 2.14326285 |
| 21 | MP0005360_urolithiasis | 2.14157479 |
| 22 | MP0001666_abnormal_nutrient_absorption | 2.07757982 |
| 23 | MP0005083_abnormal_biliary_tract | 2.06766653 |
| 24 | MP0002796_impaired_skin_barrier | 2.04379916 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 2.01270168 |
| 26 | MP0005248_abnormal_Harderian_gland | 1.98331362 |
| 27 | MP0010352_gastrointestinal_tract_polyps | 1.84223775 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.79686338 |
| 29 | MP0002098_abnormal_vibrissa_morphology | 1.76216262 |
| 30 | MP0000383_abnormal_hair_follicle | 1.73557969 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.68875789 |
| 32 | MP0000566_synostosis | 1.67313249 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.66516725 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.66380861 |
| 35 | MP0001346_abnormal_lacrimal_gland | 1.64833495 |
| 36 | MP0005332_abnormal_amino_acid | 1.63876635 |
| 37 | MP0003938_abnormal_ear_development | 1.61225336 |
| 38 | MP0004133_heterotaxia | 1.60045732 |
| 39 | MP0003252_abnormal_bile_duct | 1.57038683 |
| 40 | MP0000627_abnormal_mammary_gland | 1.56330191 |
| 41 | MP0004381_abnormal_hair_follicle | 1.54990712 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.52938693 |
| 43 | MP0006054_spinal_hemorrhage | 1.42436714 |
| 44 | MP0001661_extended_life_span | 1.41943682 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.41923827 |
| 46 | MP0003879_abnormal_hair_cell | 1.39763055 |
| 47 | MP0009384_cardiac_valve_regurgitation | 1.38508497 |
| 48 | MP0005023_abnormal_wound_healing | 1.35985225 |
| 49 | MP0001216_abnormal_epidermal_layer | 1.34102645 |
| 50 | MP0002132_abnormal_respiratory_system | 1.33321811 |
| 51 | MP0009053_abnormal_anal_canal | 1.33125662 |
| 52 | MP0001849_ear_inflammation | 1.32542117 |
| 53 | MP0001756_abnormal_urination | 1.28578319 |
| 54 | MP0000377_abnormal_hair_follicle | 1.26430539 |
| 55 | MP0000579_abnormal_nail_morphology | 1.25700739 |
| 56 | MP0005275_abnormal_skin_tensile | 1.24780870 |
| 57 | MP0005501_abnormal_skin_physiology | 1.23291290 |
| 58 | MP0002060_abnormal_skin_morphology | 1.22617899 |
| 59 | MP0005646_abnormal_pituitary_gland | 1.22399549 |
| 60 | MP0002876_abnormal_thyroid_physiology | 1.19829568 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.15359432 |
| 62 | MP0002136_abnormal_kidney_physiology | 1.14400868 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.12565362 |
| 64 | MP0003693_abnormal_embryo_hatching | 1.11140053 |
| 65 | MP0000762_abnormal_tongue_morphology | 1.10769163 |
| 66 | MP0000609_abnormal_liver_physiology | 1.08676720 |
| 67 | MP0002168_other_aberrant_phenotype | 1.07087613 |
| 68 | MP0003195_calcinosis | 1.03435791 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.02853921 |
| 70 | MP0005319_abnormal_enzyme/_coenzyme | 1.01937515 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.01401488 |
| 72 | MP0002295_abnormal_pulmonary_circulatio | 0.99511732 |
| 73 | MP0005503_abnormal_tendon_morphology | 0.99162185 |
| 74 | MP0004883_abnormal_blood_vessel | 0.98327568 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.97953081 |
| 76 | MP0003941_abnormal_skin_development | 0.97256527 |
| 77 | MP0001958_emphysema | 0.96987377 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 0.96851680 |
| 79 | MP0005395_other_phenotype | 0.95694123 |
| 80 | MP0000462_abnormal_digestive_system | 0.95279156 |
| 81 | MP0000647_abnormal_sebaceous_gland | 0.93939793 |
| 82 | MP0005451_abnormal_body_composition | 0.92647446 |
| 83 | MP0003045_fibrosis | 0.91775481 |
| 84 | MP0002896_abnormal_bone_mineralization | 0.91687399 |
| 85 | MP0003936_abnormal_reproductive_system | 0.91537504 |
| 86 | MP0000681_abnormal_thyroid_gland | 0.91476650 |
| 87 | MP0001485_abnormal_pinna_reflex | 0.91269144 |
| 88 | MP0003119_abnormal_digestive_system | 0.91235784 |
| 89 | MP0005058_abnormal_lysosome_morphology | 0.91134111 |
| 90 | MP0003186_abnormal_redox_activity | 0.89483065 |
| 91 | MP0003191_abnormal_cellular_cholesterol | 0.87310442 |
| 92 | MP0002233_abnormal_nose_morphology | 0.86214931 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.86029291 |
| 94 | MP0002108_abnormal_muscle_morphology | 0.85883733 |
| 95 | MP0002282_abnormal_trachea_morphology | 0.84558716 |
| 96 | MP0005164_abnormal_response_to | 0.83046263 |
| 97 | MP0000467_abnormal_esophagus_morphology | 0.82725558 |
| 98 | MP0002135_abnormal_kidney_morphology | 0.82458322 |
| 99 | MP0010030_abnormal_orbit_morphology | 0.81936885 |
| 100 | MP0001765_abnormal_ion_homeostasis | 0.79979104 |
| 101 | MP0000427_abnormal_hair_cycle | 0.79888305 |
| 102 | MP0003115_abnormal_respiratory_system | 0.79560897 |
| 103 | MP0000639_abnormal_adrenal_gland | 0.79461711 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.78104228 |
| 105 | MP0004084_abnormal_cardiac_muscle | 0.77113730 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.76381665 |
| 107 | MP0005257_abnormal_intraocular_pressure | 0.74518611 |
| 108 | MP0005166_decreased_susceptibility_to | 0.74361224 |
| 109 | MP0000604_amyloidosis | 0.73729167 |
| 110 | MP0005408_hypopigmentation | 0.73164136 |
| 111 | MP0005623_abnormal_meninges_morphology | 0.72943825 |
| 112 | MP0010771_integument_phenotype | 0.71823974 |
| 113 | MP0000477_abnormal_intestine_morphology | 0.71782391 |
| 114 | MP0004957_abnormal_blastocyst_morpholog | 0.70998357 |
| 115 | MP0000367_abnormal_coat/_hair | 0.70081682 |
| 116 | MP0002086_abnormal_extraembryonic_tissu | 0.69916089 |
| 117 | MP0004947_skin_inflammation | 0.69549470 |
| 118 | MP0001542_abnormal_bone_strength | 0.69479991 |
| 119 | MP0005187_abnormal_penis_morphology | 0.69180354 |
| 120 | MP0003329_amyloid_beta_deposits | 0.69087421 |
| 121 | MP0003718_maternal_effect | 0.68262008 |
| 122 | MP0008789_abnormal_olfactory_epithelium | 0.67447588 |
| 123 | MP0005076_abnormal_cell_differentiation | 0.66567225 |
| 124 | MP0000858_altered_metastatic_potential | 0.65797045 |
| 125 | MP0000598_abnormal_liver_morphology | 0.64077328 |
| 126 | MP0009931_abnormal_skin_appearance | 0.61988156 |
| 127 | MP0005075_abnormal_melanosome_morpholog | 0.61834470 |
| 128 | MP0003136_yellow_coat_color | 0.61449142 |
| 129 | MP0002928_abnormal_bile_duct | 0.60621727 |
| 130 | MP0004043_abnormal_pH_regulation | 0.58672872 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.57973435 |
| 132 | MP0001340_abnormal_eyelid_morphology | 0.57431835 |
| 133 | MP0000613_abnormal_salivary_gland | 0.57428419 |
| 134 | MP0008872_abnormal_physiological_respon | 0.57361482 |
| 135 | MP0003943_abnormal_hepatobiliary_system | 0.56725369 |
| 136 | MP0002116_abnormal_craniofacial_bone | 0.56493299 |
| 137 | MP0002160_abnormal_reproductive_system | 0.55737204 |
| 138 | MP0001177_atelectasis | 0.52681327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 6.20937819 |
| 2 | Focal segmental glomerulosclerosis (HP:0000097) | 5.12043208 |
| 3 | Lip pit (HP:0100267) | 4.78745929 |
| 4 | Glomerulosclerosis (HP:0000096) | 4.59572251 |
| 5 | Onycholysis (HP:0001806) | 4.53709259 |
| 6 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.19460178 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.06096251 |
| 8 | Gout (HP:0001997) | 4.05609480 |
| 9 | Deep venous thrombosis (HP:0002625) | 3.89650073 |
| 10 | Fragile nails (HP:0001808) | 3.82847062 |
| 11 | Morphological abnormality of the middle ear (HP:0008609) | 3.74270798 |
| 12 | Cervical subluxation (HP:0003308) | 3.69617403 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.68221973 |
| 14 | Pili torti (HP:0003777) | 3.62044397 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.60749691 |
| 16 | Alopecia of scalp (HP:0002293) | 3.56155682 |
| 17 | Esophageal varix (HP:0002040) | 3.55047686 |
| 18 | Concave nail (HP:0001598) | 3.52276001 |
| 19 | Mesangial abnormality (HP:0001966) | 3.41551990 |
| 20 | Xanthomatosis (HP:0000991) | 3.33226910 |
| 21 | Atrophic scars (HP:0001075) | 3.30378582 |
| 22 | Milia (HP:0001056) | 3.25839217 |
| 23 | Chronic bronchitis (HP:0004469) | 3.24093162 |
| 24 | Rhinitis (HP:0012384) | 3.23303134 |
| 25 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.12602865 |
| 26 | Nephritis (HP:0000123) | 3.11439422 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 3.03395589 |
| 28 | Bicornuate uterus (HP:0000813) | 3.00645460 |
| 29 | Bell-shaped thorax (HP:0001591) | 2.98873783 |
| 30 | Vascular calcification (HP:0004934) | 2.97203284 |
| 31 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.95312497 |
| 32 | Abnormal albumin level (HP:0012116) | 2.95168508 |
| 33 | Hypoalbuminemia (HP:0003073) | 2.95168508 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 2.85474063 |
| 35 | Abnormal ciliary motility (HP:0012262) | 2.82333668 |
| 36 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.82309134 |
| 37 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.82309134 |
| 38 | Abnormal pancreas size (HP:0012094) | 2.80098763 |
| 39 | Severe Myopia (HP:0011003) | 2.79075384 |
| 40 | Cardiovascular calcification (HP:0011915) | 2.78862072 |
| 41 | Abnormality of the dental root (HP:0006486) | 2.78543635 |
| 42 | Taurodontia (HP:0000679) | 2.78543635 |
| 43 | Abnormality of permanent molar morphology (HP:0011071) | 2.78543635 |
| 44 | Micronodular cirrhosis (HP:0001413) | 2.77844389 |
| 45 | Proximal tubulopathy (HP:0000114) | 2.77372328 |
| 46 | Ileus (HP:0002595) | 2.76189591 |
| 47 | Glomerulonephritis (HP:0000099) | 2.74185700 |
| 48 | Short nail (HP:0001799) | 2.73603535 |
| 49 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.68667244 |
| 50 | Polycythemia (HP:0001901) | 2.65978337 |
| 51 | Ventricular tachycardia (HP:0004756) | 2.65733694 |
| 52 | Premature rupture of membranes (HP:0001788) | 2.61261920 |
| 53 | Abnormality of molar (HP:0011077) | 2.60636536 |
| 54 | Abnormality of molar morphology (HP:0011070) | 2.60636536 |
| 55 | Absent eyebrow (HP:0002223) | 2.59881749 |
| 56 | Flat acetabular roof (HP:0003180) | 2.57540442 |
| 57 | Plantar hyperkeratosis (HP:0007556) | 2.57147134 |
| 58 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.56786015 |
| 59 | Absent/shortened dynein arms (HP:0200106) | 2.56786015 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.56522033 |
| 61 | Abnormality of the dental pulp (HP:0006479) | 2.56471482 |
| 62 | Complement deficiency (HP:0004431) | 2.55598292 |
| 63 | Pustule (HP:0200039) | 2.55154821 |
| 64 | Male infertility (HP:0003251) | 2.53262363 |
| 65 | Bronchomalacia (HP:0002780) | 2.51384126 |
| 66 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.51141159 |
| 67 | Abnormality of the nasal septum (HP:0000419) | 2.50539641 |
| 68 | Bronchiectasis (HP:0002110) | 2.49941265 |
| 69 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.48069876 |
| 70 | Abnormality of dental color (HP:0011073) | 2.46185068 |
| 71 | Hyperactive renin-angiotensin system (HP:0000841) | 2.45038983 |
| 72 | Rectal prolapse (HP:0002035) | 2.44773430 |
| 73 | Amelogenesis imperfecta (HP:0000705) | 2.43768437 |
| 74 | Myocardial infarction (HP:0001658) | 2.42948884 |
| 75 | Thyroid-stimulating hormone excess (HP:0002925) | 2.42306969 |
| 76 | Abnormality of the lacrimal duct (HP:0011481) | 2.42193772 |
| 77 | Renal tubular acidosis (HP:0001947) | 2.41379041 |
| 78 | Tubulointerstitial fibrosis (HP:0005576) | 2.40051134 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.39788400 |
| 80 | Hypobetalipoproteinemia (HP:0003563) | 2.39569487 |
| 81 | Abnormal hemoglobin (HP:0011902) | 2.38323303 |
| 82 | Absent eyelashes (HP:0000561) | 2.38102854 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35179471 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 2.35179471 |
| 85 | Hypotrichosis (HP:0001006) | 2.34576050 |
| 86 | Abdominal distention (HP:0003270) | 2.32995579 |
| 87 | Nail dystrophy (HP:0008404) | 2.31352352 |
| 88 | Curly hair (HP:0002212) | 2.30441289 |
| 89 | Abnormality of the labia majora (HP:0012881) | 2.29242213 |
| 90 | Glucose intolerance (HP:0000833) | 2.28242712 |
| 91 | Abnormality of purine metabolism (HP:0004352) | 2.27801881 |
| 92 | Biliary tract neoplasm (HP:0100574) | 2.27435819 |
| 93 | Increased purine levels (HP:0004368) | 2.27258923 |
| 94 | Hyperuricemia (HP:0002149) | 2.27258923 |
| 95 | Pterygium (HP:0001059) | 2.26960177 |
| 96 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.24956511 |
| 97 | Hyperammonemia (HP:0001987) | 2.24889083 |
| 98 | Disproportionate short-trunk short stature (HP:0003521) | 2.23885263 |
| 99 | Cone-rod dystrophy (HP:0000548) | 2.20883087 |
| 100 | Fat malabsorption (HP:0002630) | 2.20617004 |
| 101 | Abnormal hair laboratory examination (HP:0003328) | 2.18813322 |
| 102 | Vertebral hypoplasia (HP:0008417) | 2.18255518 |
| 103 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.18255518 |
| 104 | Hyperglycinuria (HP:0003108) | 2.18050379 |
| 105 | Spastic diplegia (HP:0001264) | 2.17053574 |
| 106 | Popliteal pterygium (HP:0009756) | 2.13290571 |
| 107 | Hypoplasia of the uterus (HP:0000013) | 2.13115418 |
| 108 | Aplasia cutis congenita (HP:0001057) | 2.12751534 |
| 109 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.12583985 |
| 110 | Renal salt wasting (HP:0000127) | 2.12148754 |
| 111 | Sparse lateral eyebrow (HP:0005338) | 2.10498580 |
| 112 | Hyperglycinemia (HP:0002154) | 2.09397366 |
| 113 | Sparse eyelashes (HP:0000653) | 2.08224603 |
| 114 | Microglossia (HP:0000171) | 2.07262458 |
| 115 | Synostosis involving the elbow (HP:0003938) | 2.06604299 |
| 116 | Humeroradial synostosis (HP:0003041) | 2.06604299 |
| 117 | Woolly hair (HP:0002224) | 2.05836655 |
| 118 | Abnormality of the nasolacrimal system (HP:0000614) | 2.04954332 |
| 119 | Malnutrition (HP:0004395) | 2.04088036 |
| 120 | Hyperglycemia (HP:0003074) | 2.03073791 |
| 121 | Hypoplasia of the iris (HP:0007676) | 2.02809721 |
| 122 | Abnormality of glycine metabolism (HP:0010895) | 2.01334538 |
| 123 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.01334538 |
| 124 | Infertility (HP:0000789) | 2.01265445 |
| 125 | Tongue fasciculations (HP:0001308) | 2.00129070 |
| 126 | Hypoplasia of the odontoid process (HP:0003311) | 1.97146041 |
| 127 | Ulnar bowing (HP:0003031) | 1.96624179 |
| 128 | Stridor (HP:0010307) | 1.94845647 |
| 129 | Advanced eruption of teeth (HP:0006288) | 1.94672952 |
| 130 | Abnormal blistering of the skin (HP:0008066) | 1.94581104 |
| 131 | Beaking of vertebral bodies (HP:0004568) | 1.94382610 |
| 132 | Choanal stenosis (HP:0000452) | 1.93020390 |
| 133 | Steatorrhea (HP:0002570) | 1.92807270 |
| 134 | Corneal erosion (HP:0200020) | 1.92078640 |
| 135 | Hypoplastic labia majora (HP:0000059) | 1.91563826 |
| 136 | Hemorrhage of the eye (HP:0011885) | 1.90513575 |
| 137 | Hypoplasia of dental enamel (HP:0006297) | 1.90280448 |
| 138 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.88336739 |
| 139 | Broad nasal tip (HP:0000455) | 1.87205962 |
| 140 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.87097353 |
| 141 | Stenosis of the external auditory canal (HP:0000402) | 1.86395114 |
| 142 | Wide intermamillary distance (HP:0006610) | 1.85980015 |
| 143 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85708376 |
| 144 | Abnormal tarsal ossification (HP:0008369) | 1.85348924 |
| 145 | Germ cell neoplasia (HP:0100728) | 1.84888046 |
| 146 | Ankle contracture (HP:0006466) | 1.84344613 |
| 147 | Tubulointerstitial nephritis (HP:0001970) | 1.84001213 |
| 148 | Abnormality of nucleobase metabolism (HP:0010932) | 1.83932483 |
| 149 | Abnormality of the common coagulation pathway (HP:0010990) | 1.83209870 |
| 150 | Ulnar deviation of the wrist (HP:0003049) | 1.83193026 |
| 151 | Nasolacrimal duct obstruction (HP:0000579) | 1.82898912 |
| 152 | Flattened epiphyses (HP:0003071) | 1.82423162 |
| 153 | Back pain (HP:0003418) | 1.82296252 |
| 154 | Tubular atrophy (HP:0000092) | 1.82222455 |
| 155 | Abnormality of nail color (HP:0100643) | 1.82115546 |
| 156 | Stomach cancer (HP:0012126) | 1.81360159 |
| 157 | Bifid tongue (HP:0010297) | 1.81316984 |
| 158 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.81231775 |
| 159 | Cutaneous finger syndactyly (HP:0010554) | 1.81053013 |
| 160 | Abnormality of complement system (HP:0005339) | 1.80846652 |
| 161 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.80623936 |
| 162 | Trismus (HP:0000211) | 1.79160273 |
| 163 | Abnormal biliary tract morphology (HP:0012440) | 1.77936128 |
| 164 | Abnormality of macular pigmentation (HP:0008002) | 1.77594513 |
| 165 | Ureteral duplication (HP:0000073) | 1.77432893 |
| 166 | Congenital, generalized hypertrichosis (HP:0004540) | 1.77359889 |
| 167 | Flat capital femoral epiphysis (HP:0003370) | 1.76872081 |
| 168 | Shallow orbits (HP:0000586) | 1.76674253 |
| 169 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.76589233 |
| 170 | Acanthosis nigricans (HP:0000956) | 1.76166728 |
| 171 | Abnormality of the pubic bones (HP:0003172) | 1.74869953 |
| 172 | Natal tooth (HP:0000695) | 1.74534960 |
| 173 | Abnormality of chloride homeostasis (HP:0011422) | 1.73838811 |
| 174 | Renal tubular dysfunction (HP:0000124) | 1.73428584 |
| 175 | Abnormality of the umbilical cord (HP:0010881) | 1.71725625 |
| 176 | Median cleft lip (HP:0000161) | 1.71463931 |
| 177 | Posterior subcapsular cataract (HP:0007787) | 1.71295685 |
| 178 | Severe short stature (HP:0003510) | 1.70572093 |
| 179 | Fibular aplasia (HP:0002990) | 1.69951465 |
| 180 | Abnormal cartilage morphology (HP:0002763) | 1.68824455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 2.57204124 |
| 2 | OXSR1 | 2.50868562 |
| 3 | FER | 2.40556546 |
| 4 | MST1R | 2.35458461 |
| 5 | LATS1 | 2.34653855 |
| 6 | SIK3 | 2.29963012 |
| 7 | MAP3K3 | 2.25224725 |
| 8 | TRIM28 | 2.17338986 |
| 9 | EPHB2 | 2.15228037 |
| 10 | EPHB1 | 2.12825100 |
| 11 | PAK4 | 2.05190985 |
| 12 | SIK1 | 2.04334544 |
| 13 | TRIB3 | 2.01991483 |
| 14 | EPHA2 | 10.3277745 |
| 15 | RPS6KB2 | 1.96096863 |
| 16 | FGFR4 | 1.88881196 |
| 17 | NEK9 | 1.73925025 |
| 18 | EPHA3 | 1.65023155 |
| 19 | MAP3K2 | 1.62970930 |
| 20 | PTK2 | 1.61512082 |
| 21 | FRK | 1.51107587 |
| 22 | CDK12 | 1.49853198 |
| 23 | PDK4 | 1.49253060 |
| 24 | PDK3 | 1.49253060 |
| 25 | PDK2 | 1.46306679 |
| 26 | PTK6 | 1.46147988 |
| 27 | MET | 1.39037021 |
| 28 | STK38L | 1.37858689 |
| 29 | MAP2K2 | 1.36798737 |
| 30 | TESK1 | 1.17402641 |
| 31 | NLK | 1.17073240 |
| 32 | PNCK | 1.11132549 |
| 33 | LIMK1 | 1.09946373 |
| 34 | NEK6 | 1.06161297 |
| 35 | ERN1 | 1.05494116 |
| 36 | BCKDK | 1.04977625 |
| 37 | MUSK | 1.04120170 |
| 38 | MYLK | 1.01758385 |
| 39 | GRK1 | 1.01307132 |
| 40 | STK39 | 1.01022628 |
| 41 | WEE1 | 0.96677077 |
| 42 | LRRK2 | 0.93695431 |
| 43 | RIPK1 | 0.92955435 |
| 44 | STK3 | 0.89165603 |
| 45 | ERBB2 | 0.88286999 |
| 46 | NME1 | 0.88061156 |
| 47 | FGFR2 | 0.86884938 |
| 48 | LMTK2 | 0.86729343 |
| 49 | TNIK | 0.86501069 |
| 50 | BMPR1B | 0.86420961 |
| 51 | MAP2K1 | 0.85748028 |
| 52 | TGFBR2 | 0.80235867 |
| 53 | PRKCI | 0.79165632 |
| 54 | CDK6 | 0.78918534 |
| 55 | DMPK | 0.78637712 |
| 56 | WNK4 | 0.77045709 |
| 57 | MAP2K6 | 0.76717681 |
| 58 | PIK3CA | 0.76150189 |
| 59 | PLK4 | 0.74384422 |
| 60 | AKT3 | 0.71975570 |
| 61 | BRSK2 | 0.71521740 |
| 62 | EIF2AK1 | 0.66219927 |
| 63 | PKN2 | 0.65441391 |
| 64 | TRPM7 | 0.64833659 |
| 65 | CHUK | 0.62892129 |
| 66 | ZAP70 | 0.62799676 |
| 67 | STK24 | 0.62729959 |
| 68 | MAPKAPK3 | 0.61709467 |
| 69 | PRKG2 | 0.61434134 |
| 70 | PRKD1 | 0.60865462 |
| 71 | CSNK1G1 | 0.60298941 |
| 72 | NME2 | 0.60267779 |
| 73 | FGFR1 | 0.58021186 |
| 74 | TAOK1 | 0.57992072 |
| 75 | STK10 | 0.57250415 |
| 76 | LATS2 | 0.54629099 |
| 77 | PAK3 | 0.52759542 |
| 78 | BMX | 0.52338229 |
| 79 | PRKCE | 0.51647437 |
| 80 | STK38 | 0.50716158 |
| 81 | GSK3A | 0.50017409 |
| 82 | ERBB3 | 0.49764774 |
| 83 | MAP3K11 | 0.49534244 |
| 84 | BUB1 | 0.48659468 |
| 85 | MAP3K12 | 0.46972626 |
| 86 | NUAK1 | 0.46569294 |
| 87 | MTOR | 0.45277295 |
| 88 | TBK1 | 0.44005232 |
| 89 | NEK1 | 0.43590881 |
| 90 | MAP2K3 | 0.42994253 |
| 91 | MAPK15 | 0.41615183 |
| 92 | ROCK1 | 0.41343110 |
| 93 | TLK1 | 0.39600376 |
| 94 | MAP3K1 | 0.38655330 |
| 95 | JAK1 | 0.38526488 |
| 96 | ROCK2 | 0.38169001 |
| 97 | TGFBR1 | 0.38094159 |
| 98 | DAPK2 | 0.37650467 |
| 99 | FGFR3 | 0.37196762 |
| 100 | BCR | 0.35217538 |
| 101 | RPS6KA4 | 0.34879362 |
| 102 | ILK | 0.34670340 |
| 103 | MAP3K8 | 0.34628148 |
| 104 | CDK7 | 0.34585077 |
| 105 | PAK2 | 0.33923939 |
| 106 | PAK1 | 0.33811257 |
| 107 | KDR | 0.33464828 |
| 108 | ACVR1B | 0.32797445 |
| 109 | CSNK1A1 | 0.31173700 |
| 110 | DDR2 | 0.31155007 |
| 111 | MAP3K6 | 0.30808702 |
| 112 | PDGFRB | 0.29313055 |
| 113 | TTN | 0.29269052 |
| 114 | PDGFRA | 0.29103156 |
| 115 | EIF2AK3 | 0.28842485 |
| 116 | PDPK1 | 0.28638311 |
| 117 | ABL2 | 0.27582559 |
| 118 | PIM2 | 0.27248659 |
| 119 | ERBB4 | 0.26974765 |
| 120 | IGF1R | 0.26775676 |
| 121 | MATK | 0.26628983 |
| 122 | IRAK1 | 0.26143527 |
| 123 | SGK3 | 0.25731451 |
| 124 | MELK | 0.25202736 |
| 125 | MAP3K7 | 0.25195234 |
| 126 | MINK1 | 0.25017746 |
| 127 | SCYL2 | 0.24664904 |
| 128 | CSNK1E | 0.24240287 |
| 129 | RET | 0.24011828 |
| 130 | CSNK1A1L | 0.23977968 |
| 131 | AURKB | 0.23766709 |
| 132 | PRKCD | 0.22723166 |
| 133 | CAMK2G | 0.22698250 |
| 134 | DYRK1B | 0.22310259 |
| 135 | EGFR | 0.22257985 |
| 136 | STK16 | 0.20674328 |
| 137 | ABL1 | 0.20240704 |
| 138 | MAPKAPK2 | 0.20169254 |
| 139 | IKBKB | 0.19556365 |
| 140 | PRKD2 | 0.19030312 |
| 141 | MAPKAPK5 | 0.18382717 |
| 142 | NTRK1 | 0.18186079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 4.07484608 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.89374392 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.87754400 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.63339230 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56571240 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.55673723 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.53525423 |
| 8 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.50761211 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.44389567 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.39775338 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.14553540 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.09450226 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.06301866 |
| 14 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.00995289 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.95423125 |
| 16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.93061888 |
| 17 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.89058731 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.87258397 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83627235 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.81340974 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.73878131 |
| 22 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.73554224 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72708911 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.70449680 |
| 25 | Tight junction_Homo sapiens_hsa04530 | 1.62571991 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62001071 |
| 27 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.60990543 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60724191 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58833710 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.55798987 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52027777 |
| 32 | Adherens junction_Homo sapiens_hsa04520 | 1.48128106 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.44172568 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40567409 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38728342 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38594087 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.35241942 |
| 38 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.30885559 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26653101 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.25539685 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23460023 |
| 42 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.22864475 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22452199 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20609234 |
| 45 | Proteasome_Homo sapiens_hsa03050 | 1.19898054 |
| 46 | Peroxisome_Homo sapiens_hsa04146 | 1.18888613 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.18442411 |
| 48 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.18132434 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17750110 |
| 50 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.17420024 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17344180 |
| 52 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15439805 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.10656330 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.09045864 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08859974 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 1.08812482 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08631669 |
| 58 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.08366395 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 1.07269237 |
| 60 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.03730470 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 1.02898967 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.01054232 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 1.00844122 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.99328846 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98522544 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97930753 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97719960 |
| 68 | Focal adhesion_Homo sapiens_hsa04510 | 0.94402293 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92754796 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91761685 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90723429 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90720508 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87779525 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84223749 |
| 75 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.84169890 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83780636 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83126299 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81048272 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78795155 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78496322 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75999946 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74969920 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.74670857 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73263969 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71437355 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70023320 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69999449 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68015291 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65453890 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65269096 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65255748 |
| 92 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61811233 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.61437535 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.60730485 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.60612170 |
| 96 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59072276 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58969339 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57422032 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56938862 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56678463 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.56157167 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56007850 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54526147 |
| 104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53501137 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53374015 |
| 106 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.52860874 |
| 107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.52702993 |
| 108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51420195 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.50884027 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50875119 |
| 111 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50700363 |
| 112 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50318254 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.50067590 |
| 114 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46264891 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45920538 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.45160463 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42766960 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41863723 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41271410 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41053236 |
| 121 | Axon guidance_Homo sapiens_hsa04360 | 0.40289868 |
| 122 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39684201 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.38933454 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36885212 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35651436 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35602482 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34061450 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33864366 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32689698 |
| 130 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31453279 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.31449649 |
| 132 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31021822 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.24233652 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.21719623 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.16798437 |
| 136 | Nicotine addiction_Homo sapiens_hsa05033 | 0.14388665 |
| 137 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13427179 |

